Liudi Zhang

454 total citations
17 papers, 376 citations indexed

About

Liudi Zhang is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Liudi Zhang has authored 17 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Liudi Zhang's work include Estrogen and related hormone effects (6 papers), Receptor Mechanisms and Signaling (5 papers) and Angiogenesis and VEGF in Cancer (3 papers). Liudi Zhang is often cited by papers focused on Estrogen and related hormone effects (6 papers), Receptor Mechanisms and Signaling (5 papers) and Angiogenesis and VEGF in Cancer (3 papers). Liudi Zhang collaborates with scholars based in China, Australia and United States. Liudi Zhang's co-authors include Qunyi Li, Haifei Chen, Yongli Du, Xiaojin Shi, Mingkang Zhong, Xiaojin Shi, Lu Chen, Ting Ye, Yi Wang and Yufei Wang and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Liudi Zhang

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liudi Zhang China 11 161 114 59 52 50 17 376
Zeyu Wu China 15 209 1.3× 132 1.2× 12 0.2× 127 2.4× 16 0.3× 45 595
Gibok Lee South Korea 11 252 1.6× 60 0.5× 16 0.3× 117 2.3× 23 0.5× 17 560
María C. Ruiz Argentina 15 176 1.1× 28 0.2× 35 0.6× 46 0.9× 33 0.7× 19 552
Ying-Hui Zhang China 9 140 0.9× 34 0.3× 35 0.6× 51 1.0× 28 0.6× 17 321
Honghong Wang China 14 467 2.9× 44 0.4× 24 0.4× 114 2.2× 21 0.4× 39 754
Lanlan Pan China 10 193 1.2× 30 0.3× 23 0.4× 50 1.0× 10 0.2× 31 559
Jiazhen Liang China 10 173 1.1× 75 0.7× 18 0.3× 70 1.3× 7 0.1× 14 335
Weizhen Qiao China 11 132 0.8× 55 0.5× 7 0.1× 25 0.5× 24 0.5× 17 447
Guoyu Huang China 14 238 1.5× 79 0.7× 13 0.2× 104 2.0× 10 0.2× 30 612
Woo Lee United States 9 132 0.8× 64 0.6× 25 0.4× 17 0.3× 8 0.2× 14 438

Countries citing papers authored by Liudi Zhang

Since Specialization
Citations

This map shows the geographic impact of Liudi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liudi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liudi Zhang more than expected).

Fields of papers citing papers by Liudi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liudi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liudi Zhang. The network helps show where Liudi Zhang may publish in the future.

Co-authorship network of co-authors of Liudi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Liudi Zhang. A scholar is included among the top collaborators of Liudi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liudi Zhang. Liudi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Liudi, Jesse I. Mobbs, Hariprasad Venugopal, et al.. (2025). Molecular basis of ligand binding and receptor activation at the human A3 adenosine receptor. Nature Communications. 16(1). 7674–7674.
2.
Wu, Zimei, Wenxin Zhang, Lu Chen, et al.. (2024). CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer. Pharmacological Research. 201. 107097–107097. 10 indexed citations
3.
Zhang, Liudi, Jesse I. Mobbs, Lauren T. May, Alisa Glukhova, & David M. Thal. (2023). The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors. Current Opinion in Structural Biology. 79. 102560–102560. 20 indexed citations
4.
Zhang, Wenxin, Yan Wang, Lu Chen, et al.. (2023). Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis. Molecular and Cellular Biochemistry. 479(10). 2809–2825. 4 indexed citations
5.
Wang, Tianxiao, Pengying Zhang, Lu Chen, et al.. (2021). Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway. Journal of Pharmacology and Experimental Therapeutics. 380(1). 15–25. 1 indexed citations
6.
Wang, Tianxiao, Rui Li, Yongli Du, et al.. (2021). The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 125–134. 5 indexed citations
7.
Zhu, Li, Lu Chen, Tianxiao Wang, et al.. (2021). Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China. Journal of Oncology Pharmacy Practice. 27(6). 1503–1515. 5 indexed citations
8.
Zhang, Liudi, Yingfeng Zhu, Haixia Cheng, et al.. (2018). The Increased Expression of Estrogen-Related Receptor α Correlates with Wnt5a and Poor Prognosis in Patients with Glioma. Molecular Cancer Therapeutics. 18(1). 173–184. 12 indexed citations
9.
10.
Zhang, Liudi, Jie Shao, Haifei Chen, et al.. (2018). Inhibition of PDGF-BB-induced proliferation and migration in VSMCs by proanthocyanidin A2: Involvement of KDR and Jak-2/STAT-3/cPLA2 signaling pathways. Biomedicine & Pharmacotherapy. 98. 847–855. 31 indexed citations
11.
Yang, Ning, Haifei Chen, Yongli Du, et al.. (2017). A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α. Biomedicine & Pharmacotherapy. 93. 913–922. 7 indexed citations
12.
Li, Qunyi, Lei Zhu, Liudi Zhang, et al.. (2017). Inhibition of estrogen related receptor α attenuates vascular smooth muscle cell proliferation and migration by regulating RhoA/p27 Kip1 and β-Catenin/Wnt4 signaling pathway. European Journal of Pharmacology. 799. 188–195. 12 indexed citations
13.
Du, Yongli, Liudi Zhang, Ling Hao, et al.. (2017). The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer. European Journal of Medicinal Chemistry. 136. 457–467. 24 indexed citations
14.
Kong, Biao, Lianhai Zu, Chengxin Peng, et al.. (2016). Direct Superassemblies of Freestanding Metal–Carbon Frameworks Featuring Reversible Crystalline-Phase Transformation for Electrochemical Sodium Storage. Journal of the American Chemical Society. 138(50). 16533–16541. 128 indexed citations
15.
Li, Qunyi, Yi Wang, Liudi Zhang, et al.. (2016). Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway. Fitoterapia. 111. 78–86. 51 indexed citations
16.
Zhang, Liudi, Peihong Liu, Haifei Chen, et al.. (2016). Characterization of a selective inverse agonist for estrogen related receptor α as a potential agent for breast cancer. European Journal of Pharmacology. 789. 439–448. 16 indexed citations
17.
Zhang, Liudi, Li Chen, Meng Zhang, et al.. (2015). Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway. European Journal of Pharmacology. 769. 167–176. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeyu Wu Breakdown of academic impact, for papers by Gibok Lee Breakdown of academic impact, for papers by María C. Ruiz Breakdown of academic impact, for papers by Ying-Hui Zhang Breakdown of academic impact, for papers by Honghong Wang Breakdown of academic impact, for papers by Lanlan Pan Breakdown of academic impact, for papers by Jiazhen Liang Breakdown of academic impact, for papers by Weizhen Qiao Breakdown of academic impact, for papers by Guoyu Huang Breakdown of academic impact, for papers by Woo Lee
Rankless by CCL
2026